Cargando…
Extract of Sheng-Mai-San Ameliorates Myocardial Ischemia-Induced Heart Failure by Modulating Ca(2+)-Calcineurin-Mediated Drp1 Signaling Pathways
Sheng-Mai-San (SMS) is a well-known traditional Chinese medicine (TCM) complex prescription used to treat heart failure (HF) and angina in clinic. However, its potential therapeutic mechanisms remain unclear. The present study evaluated the cardioprotection of extract of SMS (ESMS) on myocardial isc...
Autores principales: | Yang, Ye, Tian, Yushan, Hu, Siyao, Bi, Suxia, Li, Suxia, Hu, Yuanjia, Kou, Junping, Qi, Jin, Yu, Boyang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5618477/ https://www.ncbi.nlm.nih.gov/pubmed/28841143 http://dx.doi.org/10.3390/ijms18091825 |
Ejemplares similares
-
Cardioprotection by combination of three compounds from ShengMai preparations in mice with myocardial ischemia/reperfusion injury through AMPK activation-mediated mitochondrial fission
por: Li, Fang, et al.
Publicado: (2016) -
Protective Effects of Sheng-Mai-San on Right Ventricular Dysfunction during Chronic Intermittent Hypoxia in Mice
por: Chai, Cheng-Zhi, et al.
Publicado: (2016) -
The Combination of Three Components Derived from Sheng MaiSan Protects Myocardial Ischemic Diseases and Inhibits Oxidative Stress via Modulating MAPKs and JAK2-STAT3 Signaling Pathways Based on Bioinformatics Approach
por: Li, Fang, et al.
Publicado: (2017) -
Sheng Mai San protects H9C2 cells against hyperglycemia-induced apoptosis
por: Pang, Bing, et al.
Publicado: (2019) -
ShengMai-San Attenuates Cardiac Remodeling in Diabetic Rats by Inhibiting NOX-Mediated Oxidative Stress
por: Lu, Yanting, et al.
Publicado: (2021)